Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Dallas, Texas 75230


Purpose:

The primary aim is to examine whether the intake of PhosphoLEAN is effective in aiding a cohort of women in losing weight. Participants taking the supplement will have significantly greater improvement in study outcomes than those taking the placebo.


Study summary:

Participants will be randomized to either a control or treatment group taking the dietary supplement containing a soy lecithin-derived N-oleoyl-phosphatidyl-ethanolamine (NOPE) and caffeine free Green Tea-derived epigallocathchin gallate (EGCG) whose trade name is PhosphoLean. The outcome is to determine the effects on indices of weight loss and appetite suppression. Participants will return at 6, 12, and 16 weeks for clinical measures.


Criteria:

Inclusion Criteria: - 30-45 years, women, overweight or obese class I, premenopausal, maintain current diet and exercise regimen Exclusion Criteria: - pregnant or planning to become pregnant, currently have or history of cancer, heart disease, anemia, diabetes, depression


NCT ID:

NCT00153790


Primary Contact:

Principal Investigator
Conrad Earnest, PhD
The Cooper Institute


Backup Contact:

N/A


Location Contact:

Dallas, Texas 75230
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.